[{"id":3021,"name":"Elekta presents financial targets and detailed outlook ahead of Capital Markets Day","url":"https://ir.elekta.com/investors/press-releases/2026/elekta-presents-financial-targets-and-detailed-outlook-ahead-of-capital-markets-day/","date":"2026-06-17T07:30:00.000Z","intro":"<p><strong>STOCKHOLM – Elekta (EKTA-B.ST) today presents new mid-term financial targets and a more detailed outlook for fiscal year (FY) 2026/2027 ahead of its Capital Markets Day in Stockholm.</strong></p>","regulatory":true},{"id":3017,"name":"Nomination Committee’s proposal for the Board of Directors prior to Elekta’s Annual General Meeting 2026","url":"https://ir.elekta.com/investors/press-releases/2026/nomination-committees-proposal-for-the-board-of-directors-prior-to-elektas-annual-general-meeting-2026/","date":"2026-06-12T05:30:00.000Z","intro":"<p><strong>STOCKHOLM – The Nomination Committee of Elekta (EKTA-B.ST) proposes that the Annual General Meeting 2026 resolves to reelect Laurent Leksell, Ann Costello, Jan De Witte, Tomas Eliasson, Jan Kimpen, Wolfgang Reim, Jan Secher, Volker Wetekam and Cecilia Wikström, and to elect Cecilia Felton, as Directors of the Board of Directors for the period until the end of the next Annual General Meeting. Furthermore, the Nomination Committee proposes that Laurent Leksell is reelected as the Chair of the Board of Directors.</strong></p>","regulatory":false},{"id":3011,"name":"Year-end report May–April 2025/26","url":"https://ir.elekta.com/investors/press-releases/2026/year-end-report-mayapril-202526/","date":"2026-05-28T05:30:00.000Z","intro":"<p><strong class=\"mfn-heading-2\">Fourth quarter</strong></p>","regulatory":true},{"id":2998,"name":"New research presented at ESTRO 2026 highlights advances in MR-guided radiotherapy","url":"https://ir.elekta.com/investors/press-releases/2026/new-research-presented-at-estro-2026-highlights-advances-in-mr-guided-radiotherapy/","date":"2026-05-18T05:30:00.000Z","intro":"<p><strong>STOCKHOLM – Elekta (EKTA-B.ST) today announced new research on MR‑guided adaptive radiotherapy across multiple cancer indications, presented at the 2026 European Society for Radiotherapy and Oncology (ESTRO) annual congress.</strong></p>","regulatory":false},{"id":2994,"name":"Invitation to the presentation of Elekta’s fiscal year 2025/26","url":"https://ir.elekta.com/investors/press-releases/2026/invitation-to-the-presentation-of-elektas-fiscal-year-202526/","date":"2026-05-13T05:30:00.000Z","intro":"<p><strong>STOCKHOLM – Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the fiscal year 2025/26 at 9:00 a.m. CEST on May 28. The year-end report will be published at 7:30 a.m. CEST on the same day.</strong></p>","regulatory":false}]